What Is the Difference Between BPC-157 and TB-500?
The two compounds are often mentioned together because published preclinical research links both to angiogenesis (new blood vessel growth) and accelerated tissue repair in animal models — but the biological route each takes to get there differs. BPC-157's research focus includes gut-lining protection and modulation of nitric oxide signaling. TB-500's research focus centers on actin-binding activity, which affects how cells move and organize at an injury site.
Structurally, BPC-157 (≈1419 Da) is a shorter chain than TB-500 (≈1880 Da), and the two have entirely different amino acid sequences — BPC-157 is derived from a gastric protective protein, TB-500 from Thymosin Beta-4. Researchers sometimes study them in combination specifically because their proposed mechanisms are complementary rather than redundant.
Neither compound is approved for human or veterinary use in the UAE or elsewhere. Both are sold by REVIVE LAB UAE as separate SKUs — 5 mg vials, HPLC-verified, with individual Certificates of Analysis — for laboratory research use only.
| BPC-157 | TB-500 | |
|---|---|---|
| Molecular weight | ≈ 1419 Da | ≈ 1880 Da |
| Sequence length | 15 amino acids | 17 amino acids |
| Origin sequence | Gastric protective protein | Thymosin Beta-4 fragment |
| Primary research focus | Nitric oxide / growth-factor pathways, gut lining | Actin regulation, cell migration |
| HPLC purity (REVIVE LAB UAE) | ≥ 99.2% | ≥ 98.8% |
Purity ≥ 98.8% (HPLC) · Same-day Dubai dispatch · COD available · Binance Pay (5% off) Buy TB-500 UAE — Order from REVIVE LAB UAE